Profile

Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting TLR4, in order to address cancers and infectious diseases. PPI-100 activates innate immune cells, increasing antigen-presenting activities directed at tumor antigens and resulting in anti-cancer cytotoxic T-cells and long-term T-cell memory. Pattern's initial focus is on a large, white-space opportunity to address the >40% relapse rate in cancer patients 5 years after surgery. Pattern collaborates with MD Anderson, Harvard, McGill and the University of Toronto.

Pattern Pharma Inc. logo

Website

patternpharma.com

Contact

Event details

Date: January 13 - 15, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

21 in total
  • 20/20 OptimEyes Technologies Inc.
    20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for…
  • AmacaThera
    AmacaThera is a venture-backed clinical stage biotechnology company supported by institutional investors…
  • Custom Biologics
    Custom Biologics is a regulatory compliant, large molecule bioanalytical…
  • Esphera SynBio
    Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative…
  • Eurofins CDMO Alphora
    Eurofins CDMO Alphora Inc. provides integrated solutions for small molecules, drug product,…
  • GL Chemtec International Ltd.
    For over two decades, Toronto area-based GL CHEMTEC has been dedicated to delivering innovative…
  • HDAX Therapeutics
    HDAX Therapeutics is a biotechnology company pioneering a novel approach to targeting…
  • ImmunoBiochem Corporation
    ImmunoBiochem is an innovative, pharma-partnered biotech on a mission to develop novel bioconjugate therapeutics…
  • Inteligex Inc.
    Inteligex Inc. is a regenerative medicine company focused on improving clinical outcomes for patients with…
  • Iseehear Inc.
    Iseehear Inc. is a leading provider of comprehensive IT solutions for the biomedical research…
  • Mannin Research
    Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is…
  • Mediphage Bioceuticals Inc.
    Mediphage, a Toronto-based biotechnology company, has developed a proprietary and scalable manufacturing process…
  • Novel Biotechnologies Inc.
    Plasmid DNA is starting material for cell and gene, RNA and DNA therapies…
  • Nucro-Technics
    Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both…
  • Oxford Cancer Analytics Ltd.
    Oxford Cancer Analytics (OXcan) is creating a paradigm shift in early disease detection, monitoring…
  • Pattern Pharma Inc.
    Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting…
  • ProteinQure Inc.
    ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
  • PurMindsNeuroPharma
    PurMinds NeuroPharma is a neuro-medicine development company pursuing breakthrough solutions for the treatment of…
  • QurCan Therapeutics Inc.
    QurCan Therapeutics is developing tissue and cell-targeted genetic medicine using its proprietary hybrid polymer-…
  • Spiderwort Inc.
    Spiderwort is a tissue engineering company that develops cellulose-based scaffolds for use in regenerative…
  • TheraVac Biologics
    TheraVac Biologics is developing novel vaccines and immunotherapies for aging-related diseases associated with…